Perioperative Administration of Pregabalin in Laparoscopic Living Donor Nephrectomy (L-LDN) - an Adjuvance to Peroral Analgetic Treatment - a Randomized Controlled Study.

Trial Profile

Perioperative Administration of Pregabalin in Laparoscopic Living Donor Nephrectomy (L-LDN) - an Adjuvance to Peroral Analgetic Treatment - a Randomized Controlled Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2017 Primary endpoint (Pain Score given as Numeric Rating Scale (NRS) vs. time curve (AUC) 048 h) has not been met as per the results published in the Acta Anaesthesiologica Scandinavica
    • 28 Aug 2017 Primary endpoint (Opioid consumption in milligrams, 0-48 h) has been met as per the results published in the Acta Anaesthesiologica Scandinavica
    • 28 Aug 2017 Results published in the Acta Anaesthesiologica Scandinavica
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top